Novo Nordisk
Dr. Reddy’s to Expand GLP-1 Product Portfolio, Focus on Obesity and Diabetes Drug Markets
By Arun Jain
—
2024-11-05 20:42:29 : MUMBAI: Pharmaceutical major Dr. Reddy’s Laboratories Ltd aims to have around 15 GLP-1 drugs in its portfolio to treat obesity and ...